trial

Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness

NCTId NCT02845440
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 1,165 (actual)
Sponsored by Massachusetts General Hospital
Primary completion 2020-02-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
1,165 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2016-07-14
Primary completion
2020-02-02
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Academic DetailingCommunity Health Worker

Sponsors

Massachusetts General HospitalLead Sponsor
Bay Cove Human ServicesCollaborator
Brigham and Women's HospitalCollaborator
University of Massachusetts, AmherstCollaborator
VinfenCollaborator

Investigators

1
A. Eden Evins, MD, MPHPrincipal Investigator

Sites

1 total
Boston, United States

Facts & assertions

4 sourced
Enrollment
1,165
Phase
NA
Primary Completion Date
2020-02-02
Status
COMPLETED
relationships
The graph out of here
drug
Academic Detailing
drug
Community Health Worker
drug
lead_sponsor
Massachusetts General Hospital
company
collaborator
Bay Cove Human Services
company
Brigham and Women's Hospital
company
indication
Bipolar Disorder
indication
Cigarette Smoking
indication
Depressive Disorder, Major
indication
investigator
A. Eden Evins, MD, MPH
person